Search Results - "dyslipidemia"
-
1
Clinical role of apolipoproteins A and B
Published 2011-12-01Subjects: Get full textThe assessment and correction of the traditional parameters of atherogenic dyslipidemia are important, but not exclusive methods in the management of atherosclerosis, including coronary artery atherosclerosis. More accurate diagnostic and therapeutic assessment requires the measurement of apolipopro...
Article -
2
Hypertension and Hypercholesterolemia: is it Time for Anti-«Lipitensive» Therapy?
Published 2020-11-01Subjects: Get full textDespite the widespread awareness that hypertension and dyslipidemia are risk factors of prime importance for cardiovascular disease, the prevalence of these risk factors is still high, and the success of their control can hardly be considered satisfactory. The latest European guidelines for the mana...
Article -
3
Significance of dyslipidemia for primary open-angle glaucoma
Published 2022-09-01Subjects: Get full textReduction of intraocular pressure is currently considered as the main strategy to stop or slow down the progression of glaucomatous optic neuropathy. However, this goal is achieved in only 1 in 7 patients with primary open-angle glaucoma (POAG). Therefore, it is important to determine further risk f...
Article -
4
Skin manifestations of secondary dyslipidemia: a case report
Published 2022-09-01Subjects: “…dyslipidemia…”In the presented case report, 27-year-old female patient consulted a dermatologist and a lipidologist due to the appearance of small red spots on the skin. At the stage of examination in the lipid center, the patient was diagnosed with diabetes. During additional examination in the department of end...
Get full text
Article -
5
Atorvastatin effectiveness in dyslipidemia correction among coronary heart disease and arterial hypertension patients with high risk of cardiovascular complications
Published 2007-10-01Subjects: “…dyslipidemia correction…”Aim. To study the Russian atorvastatin generic (Liptonorm) effects on lipid metabolism in patients with coronary heart disease (CHD), essential arterial hypertension (EAH), and high risk of cardiovascular complications (CVC). Material and methods. In total, 30 patients (17 men, 13 women; mean age 52...
Get full text
Article -
6
APOLIPOPROTEIN A1 GENE AND ITS ROLE IN DYSLIPIDEMIA DEVELOPMENT ACROSS ETHNIC GROUPS OF PATIENTS WITH ESSENTIAL ARTERIAL HYPERTENSION
Published 2012-12-01Subjects: Get full textAim. To assess the impact of insertion-deletion polymorphism of apolipoprotein A gene on the development of dyslipidemia among adolescents with essential arterial hypertension (EAH), in regard to the ethnic group: non-indigenous Slavic vs. indigenous Buryat. Material and methods. In total, 399 adole...
Article -
7
Cardiovascular risk factors in children with hereditary loading
Published 2020-03-01Subjects: Get full textAim. To study the prevalence of CVRF in schoolchildren with a family history of atherosclerosis-related cardiovascular disease.Material and methods. The study included 106 schoolchildren aged 10 to 17 years. The main group consisted of children (n=55) with a family history of cardiovascular diseases...
Article -
8
TREATMENT OF PATIENTS WITH SEVERE DYSLIPIDEMIA IN REAL CLINICAL PRACTICE
Published 2015-09-01Subjects: Get full textCardiovascular diseases remain the most common cause of death in Russia. In real clinical practice doctors are more focused on the modification of other major risk factors rather than on the correction of dyslipidemia, or pay more attention to secondary prevention of cardiovascular diseases.Aim. To...
Article -
9
New features correction of the dyslipidemia in patients with diabetes mellitus and metabolic cardiovascular risk factors
Published 2014-04-01Subjects: Get full textThe prospects of using new drug of statine class – pitavastatine – in the prophylaxis and treatment of cardiovascular diseases have been considered in this review. The data of international іnvestigations on the comparative effi cacy of pitavastatine have been given; its pleiotropic effects, high...
Article -
10
Associations of polyphenolic compounds consumption and the risk of dyslipidemia in the Siberian population
Published 2020-06-01Subjects: Get full textAim. To identify associations of polyphenols consumption in general, as well as their classes with the risk of dyslipidemia in the population of Novosibirsk aged 45-69.Material and methods. In 2003-2005, in the frames of the HAPIEE international project “Determinants of cardiovascular diseases in Ea...
Article -
11
Combined hypolipidemic therapy in patients who failed to achieve target values of the lipidogram. Possibilities of ezetimibe
Published 2021-06-01Subjects: “…dyslipidemia…”Clinical cases of effective use of combined lipid-lowering therapy (statin and ezetimibe) in patients with extremely high risk, who failed to achieve the target values of the level of low-density lipoprotein cholesterol were presented. Use of this drug combination allowed to achieve the target value...
Get full text
Article -
12
EFFICACY OF VARIOUS DRUG FORMS OF LYCOPENE IN PATIENTS WITH DYSLIPIDEMIA
Published 2016-01-01Subjects: Get full textAim. To find the optimal scheme of lycopene application and to compare clinical efficacy of two lycopene presentations produced on the basis of 1) vegetable oil and 2) milk protein (lactolycopene) in patients with dyslipidemia.Material and methods. At the first step of the study to choice an optimal...
Article -
13
Demodicosis Cutis and Metabolic Disturbances
Published 2022-06-01Subjects: Get full textCutaneous demodicosis (CD) is a pilosebaceous unit disease, overlapping clinically with other facial dermatoses, mainly rosacea, and acne. It is usually improved by acaricidal monotherapy. This study investigates the association of CD with metabolic disturbances. It was conducted with 141 patients w...
Article -
14
Effective polypill therapy in patients with hypertension and dyslipidemia
Published 2025-07-01Subjects: Get full textAim. To identify factors associated with achieving the target blood pressure (BP) and low-density lipoprotein cholesterol (LDL-C) levels with polypill therapy (indapamide, perindopril, rosuvastatin) in patients with hypertension (HTN) and dyslipidemia after a coronavirus disease 2019.Material and me...
Article -
15
Evaluation of cardiometabolic risk factors in women with breast cancer before and after chemotherapy with doxorubicin and cyclophosphamide
Published 2025-02-01Subjects: Get full textAim. To evaluate cardiometabolic risk (CMR) factors in women with breast cancer (BC) before and after chemotherapy (CT) with doxorubicin and cyclophosphamide.Material and methods. This prospective cohort study included 154 women with a median age of 43 years with newly diagnosed stage IIA-IIIB BC. T...
Article -
16
Lipid profile changes after the acute COVID-19 period. Sub-analysis of the International Registry "Dynamics Analysis of Comorbidities in SARS-CoV-2 Survivors" (AKTIV SARS-CoV-2)" (...
Published 2024-04-01Subjects: Get full textAim. To analyze the lipid profile changes during the acute phase of coronavirus disease 2019 (COVID-19) and within 12 months after discharge from the hospital (post-Covid period) in comparison with the lipid profile of patients before COVID-19.Material and methods. The subanalysis of the registry wa...
Article -
17
Hemorheological parameters in patients with arterial hypertension and lipid metabolism disorders
Published 2010-02-01Subjects: Get full textAim. To study hemorheological disturbances in patients with essential arterial hypertension (AH) and dyslipidemia (DLP). Material and methods. In total, 83 AH patients without target organ disease were examined, including 30 without lipid metabolism disorders and 53 with DLP (total cholesterol, TCH...
Article -
18
Modulation of the intestinal microbiota as a means of primary and secondary prevention of cardiovascular catastrophes
Published 2023-11-01Subjects: Get full textBackground. Cardiovascular diseases associated with dyslipidemia are the leading causes of mortality and disability of the population. The peculiarities of drug therapy of hypercholesterolemia dictate the need to take into account the individual characteristics of patients, among whom persons with c...
Article -
19
PLATELET HEMOSTASIS DYNAMICS IN SIMVASTATINTREATED PATIENTS WITH ARTERIAL HYPERTENSION AND DYSLIPIDEMIA
Published 2010-02-01Subjects: Get full textAim: To assess simvastatin effectiveness in lipid profile and platelet activity correction among patients with arterial hypertension (AH) and dyslipidemia. Material and methods. In total, 34 patients received simvastatin for 4 months. The dynamics of lipid profile, lipid peroxidation in plasma and p...
Article -
20
DYSLIPIDEMIA FEATURES IN CHILDREN
Published 2016-01-01Subjects: “…dyslipidemia…”Contemporary scientific and practical data about various lipid metabolism disorders (dyslipidemia) in children are discussed. Spectra lipids, phospholipids and lipoproteins in blood serum and erythrocyte membranes are presented. Characteristics of dyslipidemia and hypolipidemia, classification of hy...
Get full text
Article